Detection of non-adherent behaviour in early psychosis

Australian and New Zealand Journal of Psychiatry

Volumn 40, Issue 5, 2006, Pages 446-451

  Hui, Christy L M ^a   Chen, Eric Y H ^a   Kan, C S ^b   Yip, K C ^c   Law, C W ^d   Chiu, Cindy P Y ^d  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CASTLE PEAK HOSPITAL   (Hong Kong)

^c KOWLOON HOSPITAL   (Hong Kong)

^d QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Compliance; Early psychosis; Medication adherence; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG WITHDRAWAL; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; PROBABILITY; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; QUESTIONNAIRE; RATING SCALE; SELF CONCEPT; SELF REPORT; SOCIAL BEHAVIOR;

ADULT; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOTIC DISORDERS; QUESTIONNAIRES; SCHIZOPHRENIA;

EID: 33646200237     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1111/j.1440-1614.2006.01821.x     Document Type: Article

References (20)

1. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophrenia Bulletin 1997; 23: 637-651.
2. Dolder CR, Lacro JP, Leckband S, Jeste DV. Interventions to improve antipsychotic medication adherence: Review of recent literature. Journal of Clinical Psychopharmacology 2003; 23: 389-399.
3. Coldham EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica 2002; 106: 286-290.
4. World Health Organization. Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization, 2003.
5. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: Three decades of research. A comprehensive review. Journal of Clinical Pharmacy and Therapeutics 2001; 26: 331-342.
6. Morris LS, Schulz RM. Patient compliance - an overview. Journal of Clinical Pharmacy and Therapeutics 1992; 17: 283-295.
7. Bebbington PE. The content and context of compliance. International Clinical Psychopharmacology 1995; 5: 41-50.
8. Hudson TJ, Owen RR, Thrush CR et al. A pilot study of barriers to medication adherence in schizophrenia. Journal of Clinical Psychiatry 2004; 65: 211-216.
9. Kampman O, Laippala P, Vaananen J et al. Indicators of medication compliance in first-episode psychosis. Psychiatry Research 2002; 110: 39-48.
10. Agarwal MR, Sharma VK, Kishore Kumar KV, Lowe D. Non-compliance with treatment in patients suffering from schizophrenia: A study to evaluate possible contributing factors. International Journal of Social Psychiatry 1998; 44: 92-106.
11. Mihalopoulos C, McGorry PD, Carter RC. Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome? Acta Psychiatrica Scandinavica 1999; 100: 47-55.
12. Mutsatsa SH, Joyce EM, Hutton SB et al. Clinical correlates of early medication adherence: West London first episode schizophrenia study. Acta Psychiatrica Scandinavica 2003; 108: 439-446.
13. Chen E. Developing an early intervention service in Hong Kong. In: Ehmann T, MacEwan GW, Honer WG, eds. Best care in early psychosis intervention: Global perspectives. London and New York: Taylor & Francis, 2004; 125-130.
14. Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research 2000; 42: 241-247.
15. Birchwood M. Early intervention and sustaining the management of vulnerability. Australian and New Zealand Journal of Psychiatry 2000; 34 (Suppl.): S181-S184.
16. Barber N. Should we consider non-compliance a medical error? Quality and Safety in Health Care 2002; 11: 81-84.
17. Vander SR. Measurement of patient compliance and the interpretation of randomized clinical trials. European Journal of Clinical Pharmacology 1991; 41: 27-35.
18. Jeste SD, Patterson TL, Palmer BW, Dolder CR, Goldman S, Jeste DV. Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophrenia Research 2003; 63: 49-58.
19. Kampman O, Lehtinen K, Lassila V, Leinonen E, Poutanen O, Koivisto A. Attitudes towards neuroleptic treatment: Reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire. Schizophrenia Research 2000; 45: 223-234.
20. Kemp R, Kirov G, Everitt B, Hayward P, David A. Randomised controlled trial of compliance therapy. 18-month follow-up. British Journal of Psychiatry 1998; 172: 413-419.